Monday, October 26, 2026
Home Authors Posts by Ogkologos

Ogkologos

4382 POSTS 0 COMMENTS

New Translations of the ESMO Patient Guides Available in Estonian

Ogkologos -
0

Trend in Survival Benefit with a Combination of Spartalizumab Plus Dabrafenib...

Ogkologos -
0

FDA Approves Pembrolizumab or Pembrolizumab and Berahyaluronidase alfa-pmph Each with Enfortumab...

Ogkologos -
0

Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years...

Ogkologos -
0

Metastatic Breast Cancer: ESMO Living Guideline

Ogkologos -
0

No Additional Benefit From Tiragolumab Plus Atezolizumab Over Durvalumab in Locally...

Ogkologos -
0

EMA Recommends Extension of Indications for Datopotamab Deruxtecan

Ogkologos -
0

High-Dose Chemotherapy Followed by ASCT Improves Survival Compared with Non-myeloablative Consolidation...

Ogkologos -
0

ESMO Clinical Practice Guideline Express Update on daraxonrasib in the treatment...

Ogkologos -
0

FDA Approves Isatuximab-irfc for Subcutaneous Injection for Multiple Myeloma Indications

Ogkologos -
0
1...678...439Page 7 of 439

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com